Drug Type CAR-T |
Synonyms BH-002 |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Granulomatosis With Polyangiitis | Phase 2 | China | 10 Jul 2024 | |
Idiopathic Inflammatory Myopathies | Phase 2 | China | 10 Jul 2024 | |
Lupus Nephritis | Phase 2 | China | 10 Jul 2024 | |
Microscopic Polyangiitis | Phase 2 | China | 10 Jul 2024 | |
Scleroderma, Systemic | Phase 2 | China | 10 Jul 2024 | |
Primary Sjögren's syndrome | Phase 2 | China | 29 May 2024 |